Amundi
EHC icon

Amundi’s Encompass Health EHC Stock Holding History

Amundi’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.52M Sell
88,096
-2,319
-3% -$238K ﹤0.01% 895
2025
Q4 		$9.6M Buy
90,415
+2,300
+3% +$267K ﹤0.01% 945
2025
Q3 		$10.9M Sell
88,115
-104,197
-54% -$12.4M ﹤0.01% 846
2025
Q2 		$22.9M Buy
192,312
+7,552
+4% +$863K 0.01% 686
2025
Q1 		$18.8M Sell
184,760
-7,512
-4% -$733K 0.01% 721
2024
Q4 		$17.9M Sell
192,272
-137,419
-42% -$13.5M 0.01% 740
2024
Q3 		$30.8M Buy
329,691
+329,362
+100,110% +$29.6M 0.01% 639
2024
Q2 		$28.4K Sell
329
-287,859
-100% -$24.2M ﹤0.01% 1823
2024
Q1 		$22.7M Sell
288,188
-1,748
-0.6% -$128K 0.01% 685
2023
Q4 		$19.8M Buy
289,936
+29,108
+11% +$1.89M 0.01% 720
2023
Q3 		$16.6M Buy
260,828
+72,046
+38% +$4.96M 0.01% 736
2023
Q2 		$12.7M Buy
188,782
+68,512
+57% +$4.29M 0.01% 794
2023
Q1 		$7.34M Buy
+120,270
New +$7M ﹤0.01% 917

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Amundi's EHC Position: Q1 2026 in Review

Amundi reduced its Encompass Health (EHC) stake by 2.6% in Q1 2026, selling an estimated $238K and leaving 88,096 shares worth $8.52M. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Amundi first reported a position in EHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $30.8M in Q3 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Amundi held 88,096 shares of Encompass Health worth $8.52M as of Q1 2026.
  • Amundi sold 2,319 Encompass Health shares in Q1 2026, an estimated $238K.
  • Encompass Health made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #895 holding.
  • Amundi first reported a position in Encompass Health in Q1 2023 and has held it in 13 quarters since.
  • Amundi's Encompass Health position peaked at $30.8M in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.